ProCE Banner Activity

How I Treat Behçet’s Disease

Clinical Thought
Most patients with Behçet’s present with mucocutaneous manifestations. Here’s my take on current options for these lesions.

Share

Faculty

Yusuf Yazici

Yusuf Yazici, MD

Clinical Associate Professor of Medicine
Department of Rheumatology
New York University School of Medicine
New York, New York

Supporters

Celgene without Corporation

Faculty Disclosure

Primary Author

Yusuf Yazici, MD

Clinical Associate Professor of Medicine
Department of Rheumatology
New York University School of Medicine
New York, New York

Yusuf Yazici, MD, has disclosed that he has received funds for research support from Bristol-Myers Squibb, Celgene, and Genentech and consulting fees from Celgene and Sanofi.